Rituximab as an adjuvant therapy for pemphigus: experience in 61 patients from a single center with long-term follow-up.

Rituximab is a safe and effective adjuvant in the treatment of pemphigus. Treatment outcomes were better for patients who received rituximab as first-line treatment, but the difference was not statistically significant.